ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.990
+0.010 (0.51%)
Nov 21, 2024, 10:49 AM EST - Market open
ADC Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for ADC Therapeutics stock have an average target of 7.33, with a low estimate of 6.00 and a high estimate of 8.00. The average target predicts an increase of 268.34% from the current stock price of 1.99.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ADCT stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 2 | 2 | 2 | 2 | 2 | 3 |
Hold | 3 | 3 | 2 | 2 | 2 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 7 | 6 | 6 | 6 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stephens & Co. | Stephens & Co. | Buy Initiates $6 | Buy | Initiates | $6 | +201.51% | Nov 8, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +302.01% | Aug 8, 2024 |
RBC Capital | RBC Capital | Buy Reiterates $8 | Buy | Reiterates | $8 | +302.01% | Aug 7, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | May 30, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +302.01% | May 7, 2024 |
Financial Forecast
Revenue This Year
74.19M
from 69.56M
Increased by 6.66%
Revenue Next Year
86.34M
from 74.19M
Increased by 16.38%
EPS This Year
-5.21
from -2.94
EPS Next Year
-6.42
from -5.21
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 78.0M | 102.2M | 145.8M | ||
Avg | 74.2M | 86.3M | 118.8M | ||
Low | 69.7M | 77.5M | 80.3M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 12.1% | 37.8% | 68.9% | ||
Avg | 6.7% | 16.4% | 37.6% | ||
Low | 0.2% | 4.5% | -7.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -1.63 | -1.34 | -0.92 |
Avg | -5.21 | -6.42 | -1.25 |
Low | -21.56 | -29.40 | -1.71 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.